Aminophylline for methotrexate-induced neurotoxicity

The Lancet

Volumn 345, Issue 8949, 1995, Pages 544-547

  Bernini, J C ^a   Fort, D W ^a   Griener, J C ^a   Kane, B J ^a   Chappell, W B ^a   Kamen, B A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; AMINOPHYLLINE; CENTRAL DEPRESSANT AGENT; CYTARABINE; FOLINIC ACID; HYDROCORTISONE; METHOTREXATE; NARCOTIC AGENT; PARACETAMOL; PROMETHAZINE; SEROTONIN ANTAGONIST; STEROID; THEOPHYLLINE;

ADOLESCENT; ANOREXIA; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEADACHE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHATIC LEUKEMIA; NAUSEA; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PARALYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PURINE SYNTHESIS; SEIZURE; SOMNOLENCE;

EID: 0028919570     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)90464-6     Document Type: Article

References (30)

1. Second line drug therapy for rheumatoid arthritis
2. Long term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis
3. Methotrexate and leukemia
4. Folic acid antagonists
5. Inhibition of phosphoribosyl-aminoimidizolecarboxamide transformylase by methotrexate and dihydrofolic acid polyglutamates
6. Karnofsky memorial lecture: ode to methotrexate
7. Therapy related central nervous system diseases in children with acute lymphoblastic leukemia
8. Neurologic sequelae of methotrexate and ionizing radiation: a new classification
9. Chronic neurologic disturbance in childhood leukemia
10. Neurotoxicity due to central nervous system therapy for childhood leukemia
11. Modulation of potassium evoked secretory function in rat cerebellar slices measured by real time monitoring: evidence of a possible role for methylfolate in cerebral tissue
12. Kainate-like neurotoxicity in folates
13. Folic acid—an innocuous means to reduce plasma homocysteine
14. Methotrexate folate and the brain
15. Effects of methotrexate on astrocytes in primary culture: light and electron microscopic studies
16. The anti-inflammatory mechanism of methotrexate: increased adenosine release at inflamed sites diminishes leucocyte accumulation in an in vivo model of inflammation
17. Novel therapeutics acting via purine receptors
18. Drugs used in the treatment of asthma
19. An improved assay for adenosine in microdialysates using microbore high performance liquid chromatography
20. Subtraction method for the high performance liquid chromatographic measurement of plasma adenosine
21. Application of a variance stabilising transformation approach to linear regression of calibration lines
22. Cardiovascular effects of adenosine in man: possible clinical implications
23. Prolonged intensive oral methotrexate does not induce its own malabsorption
24. Intermediate dose intravenous methotrexate and 6-mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group pilot study
25. Effect of chronic methotrexate treatment on tissue levels of folate and methotrexate polyglutamates
26. Methotrexate accumulation in rat brain is independent of irradiation and drug schedule
27. Pentostatin: an adenosine deaminase inhibitor for the treatment of hairy cell leukemia
28. Cytarabine and neurologic toxicity
29. Antagonistic effects of theophylline and adenosine on adrenergic neuroeffector transmission in the rabbit kidney
30. A new folate antimetabolite, 5,10-dideazatetrahydrofolate is a potent inhibitor of de novo purine synthesis